Skip to main content
Premium Trial:

Request an Annual Quote

Former Pharmacopeia Exec Named COO, President of Senomyx

NEW YORK, May 8 – Saiid Zarrabian, who resigned as chief operating officer at Pharmacopeia in December, has been appointed president and COO of Senomyx, a developer of flavor and fragrance molecules that can be used in consumer products, Senomyx said Tuesday.

"Mr. Zarrabian brings tremendous knowledge to Senomyx, particularly in the area of chemical and biological simulations and analysis systems, as well as drug discovery process,” Senomyx CEO Paul Grayson said in a statement.

“I am confident Mr. Zarrabian's wealth of experience and strong leadership skills will bring Senomyx closer to our goal of being the leader in the discovery of proprietary technology for consumer-based products," said Grayson.

At Pharmacopeia, Zarrabian helped to build the company both organically and through mergers and acquisitions, said Senomyx, which is based in La Jolla, Calif.

Zarrabian will replace Grayson in the role of president.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.